Medical device companies and their supply chains are more dispersed than ever. Everyone involved in new product development and introduction (NPDI) needs to share, review, and use the latest product and quality information to ensure safe and effective products can be built as designed. And, all processes must comply with the FDA and other regulating bodies.
Arena manages the key elements of design controls while accelerating innovation. Your quality, engineering, and operations teams can quickly establish, document, and follow compliant procedures.
Developing medical devices requires adherence to FDA, EMA, ISO, and other regulations. Arena’s design control capabilities simplify your review, verification, and validation processes. Arena QMS speeds design changes and transfers by establishing and tracking design control elements: user needs, design inputs, design processes, design outputs, and device documentation.
link CAPA processes with the product record to close the quality-to-product loop
demonstrate that design controls processes are established and followed
create, modify, and share the latest design outputs for review, verification, and validation
manages dynamic user needs as requirements and links them with design inputs and outputs
have role-based controls to securely review and approve product releases and changes
review and analyze proposed product designs for DFM consideration
Arena’s solutions helps you establish strong design controls to give your teams the confidence needed to face audits.
Medical device companies know that effective design controls lead to high-quality products. With Arena, your product teams can establish, document, and follow compliant design controls. This enables teamwide visibility into your product and quality records. Arena QMS provides the necessary design controls to help you deliver innovative, compliant medical products fast.
“We incorporate risk management throughout the design controls process per 21 CFR Part 820.30. Risk management starts early in the design process, when user needs and design inputs are defined. This early identification of risks helps us manage and deliver successful design verification and validation results.”
Vis Ayer Senior Director, Nevro